Fitch Ratings has affirmed Nouryon Holding B.V.'s (Nouryon) Long-Term Issuer Default Rating (IDR) at 'B+' with Stable Outlook.

Fitch has also affirmed Nouryon Finance B.V.'s senior secured rating at 'BB-' with a Recovery Rating of 'RR3' and senior unsecured ratings at 'B-' with a Recovery Rating of 'RR6' based on the current capital structure.

We do not expect an impact on the senior secured rating from Nouryon's new capital structure following the spin-off of Nobian Holding 2 B.V. (B+(EXP)/Stable) based on current assumptions.

The rating reflects high funds from operations (FFO) gross leverage following the acquisition by The Carlyle Group and GIC in 2018, which constrains the rating. This is despite the company's solid business profile and resilient cash flows, further strengthened by achieved cost savings.

The Stable Outlook reflects the balance between the company's fairly predictable EBITDA generation as a pure specialty chemicals company with leading positions in niche markets, and a highly leveraged capital structure, albeit with a focus on gradual debt repayment.

KEY RATING DRIVERS

Nobian Sale Broadly Neutral: We estimate that the sale of Nobian will reduce Nouryon's sales, EBITDA and gross debt by approximately EUR1 billion, EUR300 million and EUR1.5 billion, respectively, resulting in broadly similar net debt/EBITDA ratio pre-and post-sale. Nouryon will be fully focused on specialty chemicals, which supports stable cash flow generation, but scale and diversification will somewhat decline. However, we expect Nouryon's EBITDA to return to 2020 levels by 2024, driven by steady growth and cost initiatives.

As the two businesses had limited synergies and different strategies - as Nobian is a regional producer of more commoditised chemicals - we believe the sale is part of the strategic options considered by Nouryon's shareholders.

Debt Reduction: Following the carve-out of Nobian, Nouryon plans to use the proceeds to repay senior unsecured notes and part of its US dollar term loan B (TLB). Based on the current assumptions we do not expect the new capital structure to affect the senior secured rating.

Increased Standalone Margins: Fitch views Nouryon's strong 2020 performance as reflective of the company's focus on diversified and resilient end-markets, product differentiation, cost reductions and portfolio optimisation. Excluding the higher-margin Nobian, Nouryon's Fitch-adjusted EBITDA margin grew to 22.7% in 2020 from below 18% in 2018. We believe that Nouryon will maintain EBITDA margins above 22% and will grow revenue by around 4% per year, slightly above market growth, on successful product launches, capacity additions and inorganic growth.

Robust FCF Underpins Deleveraging: We expect Nouryon to generate recurring positive free cash flow (FCF) in the next four years, supporting a reduction of FFO gross leverage to below 5x in 2024 from 6.3x in 2020. While mandatory debt repayments are modest at about EUR40 million per year, we believe that Nouryon will allocate part of FCF to voluntary debt repayments, as seen in November 2020 when it repaid EUR100 million and in October 2019 when it repaid EUR110 million of the US dollar TLB. We project that it will have the capacity to further reduce its gross debt depending on its capital-allocation strategy.

Bolt-On Acquisitions to Continue: During 2020, Nouryon acquired the carboxymethyl cellulose (CMC) business from J.M. Huber Corporation and the merchant triethyl aluminium (TEAL) business of Sasol, and divested its re-dispersible polymer powders business to Celanese, for a net outflow of EUR109 million. These acquisitions reinforced Nouryon's leadership in CMC and metal alkyls. We understand from management that they intend to maintain this external growth strategy, albeit selectively, and therefore assume EUR100 million M&A outflow per year, targeting bolt-on acquisitions in key end-markets such as polymer specialties, paints & coatings, agriculture or personal care.

Barriers to Entry: Fitch views significant barriers to entry to Nouryon's leading positions in niche markets, as the company specialises in products that are either providing differentiated or tailor-made properties, or that are key in the manufacturing process of a final product. This supports steady volumes, as seen in 2020 when they declined only 2%. Nouryon's R&D investments amount to around 3% of sales, and result in several new product launches every year.

No Dividend Assumed: We expect Carlyle to prioritise deleveraging and bolt-on acquisitions in the coming years. Clauses in Nouryon's debt documentation permit dividends below a certain leverage level but the company's leverage metrics remain above this threshold under our forecast. We believe that a significant shareholder distribution would not be consistent with the current strategy to voluntarily repay debt when feasible.

Regulatory Risk: An increasing focus by governments on more environmentally friendly manufacturing methods results in expensive and time-intensive adjustments to ensure compliance. While this could generally constitute a risk to the ability of Nouryon to sell its products, Fitch believes that it is unlikely to be negatively affected, given its proactivity to ensure the business remains compliant.

DERIVATION SUMMARY

Most of Nouryon's specialty chemicals peers in EMEA, such as BASF SE (A/Stable), Solvay SA (BBB/Stable) or Akzo Nobel N.V. (BBB+/Stable), are higher-rated due to significantly lower leverage, and their leading positions in larger-scale products globally. However, Nouryon has higher EBITDA and FCF margins, and is a leader in niche markets.

Nouryon is larger and more diversified across stable markets and has higher FCF margin than Roehm Holding GmbH (B-/Stable), Root Bidco S.a.r.l. (B/Stable), Petkim Petrokimya Holdings A.S. (B/Stable), Nobian Holding 2 B.V. (B+(EXP)/Stable), or Synthos Spolka Akcyjna (BB/Stable), the latter three being regional suppliers. It is however smaller and less diversified than Ineos Quattro Holdings Limited (BB/Stable), which also has lower leverage. Nouryon's FFO gross leverage is higher than Petkim's or Synthos', but comparable to Nobian's, Roehm's or Rovensa's.

KEY ASSUMPTIONS

Fitch's Key Assumptions Within its Rating Case for the Issuer

Revenues to grow on average 3%-4% over 2021-2024

EBITDA margin on average at 22%-23% over 2021-2024

Annual capex on average at 6.5% of sales

M&A of EUR100 million per year from 2022 until 2024

Assumed voluntary annual debt repayments of EUR150 million in 2022, 2023 and 2024 based on company's willingness to deleverage

No common dividends

Key Recovery Analysis Assumptions

The recovery analysis assumes that Nouryon would be reorganised as a going-concern (GC) in bankruptcy rather than liquidated.

The GC EBITDA estimate reflects Fitch's view of a sustainable, post-reorganisation EBITDA level upon which we base the enterprise valuation.

The GC EBITDA of EUR787 million reflects changes in regulation or substantial external pressures, such as a severe global downturn that particularly hits Nouryon's main end-markets, resulting in heavily reduced demand for Nouryon's products, but also considers corrective measures taken in the reorganisation to offset adverse conditions.

Fitch uses a multiple of 5.5x to estimate a GC enterprise value for Nouryon because of its leadership position, resilient exposure to non-cyclical end-markets, solid profitability and higher barriers to entry due to substantial R&D needs for product development.

The recovery analysis is based on the existing capital structure.

Fitch assumes the company's revolving credit facility (RCF) to be fully drawn and to rank pari passu with the TLB and other senior secured debt.

After deduction of 10% for administrative claims, Fitch's waterfall analysis generated a waterfall generated recovery computation (WGRC) for the senior secured instrument in the 'RR3' band, indicating a 'BB-' instrument rating and a WGRC for the senior unsecured instrument in the 'RR6' band, indicating a 'B-' rating. The WGRC output percentage on current metrics and assumptions was 65% for the senior secured debt and 0% for the senior unsecured debt.

RATING SENSITIVITIES

Factors that could, individually or collectively, lead to positive rating action/upgrade:

FFO gross leverage below 5.0x on a sustained basis

FFO interest coverage above 3.5x on a sustained basis

EBITDA margin sustained above 23% and FCF margins above 5% through achieved synergies and cost savings

Factors that could, individually or collectively, lead to negative rating action/downgrade:

FFO gross leverage above 7.0x on a sustained basis

FFO interest coverage below 2.5x on a sustained basis

Weakening EBITDA and FCF margins; for example, as a result of lost market share or adverse regulatory changes

BEST/WORST CASE RATING SCENARIO

International scale credit ratings of Non-Financial Corporate issuers have a best-case rating upgrade scenario (defined as the 99th percentile of rating transitions, measured in a positive direction) of three notches over a three-year rating horizon; and a worst-case rating downgrade scenario (defined as the 99th percentile of rating transitions, measured in a negative direction) of four notches over three years. The complete span of best- and worst-case scenario credit ratings for all rating categories ranges from 'AAA' to 'D'. Best- and worst-case scenario credit ratings are based on historical performance. For more information about the methodology used to determine sector-specific best- and worst-case scenario credit ratings, visit https://www.fitchratings.com/site/re/10111579.

LIQUIDITY AND DEBT STRUCTURE

Comfortable Liquidity: As of 31 March 2021, Nouryon maintained liquidity of approximately EUR1 billion, consisting of EUR375 million of cash and about EUR640 million of its undrawn revolver, excluding EUR109 million as security for cash management and trade-finance facilities. This compared with about EUR40 million of mandatory TLB amortisation and about EUR50 million of other current financial liabilities. Post disposal of Nobian, Fitch expects Nouryon to have about EUR800 million of liquidity as the RCF is being downsized to USD637 million (about EUR524 million).

Fitch expects Nouryon to generate positive FCF over the next four years. Fitch views this level of liquidity as sufficient to cover debt repayments in the coming four years while allowing flexibility to make voluntary debt repayments and realise acquisitions.

ISSUER PROFILE

Post-Nobian spin-off, Nouryon is a Netherland-based producer of specialty chemicals used in a broad range of sectors, owned by The Carlyle Group and GIC since 2018.

SUMMARY OF FINANCIAL ADJUSTMENTS

For 2020:

Lease liabilities of EUR159 million excluded from financial debt; depreciation of right-of-use assets (EUR48 million) and lease-related interest expense (EUR8 million) deducted from EBITDA and cash flow from operations.

EUR126 million added back to EBITDA and EUR87 million to FFO to remove non-recurring or non-cash costs.

REFERENCES FOR SUBSTANTIALLY MATERIAL SOURCE CITED AS KEY DRIVER OF RATING

The principal sources of information used in the analysis are described in the Applicable Criteria.

ESG CONSIDERATIONS

Unless otherwise disclosed in this section, the highest level of ESG credit relevance is a score of '3'. This means ESG issues are credit-neutral or have only a minimal credit impact on the entity, either due to their nature or the way in which they are being managed by the entity. For more information on Fitch's ESG Relevance Scores, visit www.fitchratings.com/esg

RATING ACTIONSENTITY/DEBT	RATING	RECOVERY	PRIOR Nouryon Finance B.V.		 			

senior unsecured

LT	B- 	Affirmed	RR6	B-

senior secured

	LT	BB- 	Affirmed	RR3	BB-
Nouryon Holding B.V.	LT IDR	B+ 	Affirmed		B+

VIEW ADDITIONAL RATING DETAILS

Additional information is available on www.fitchratings.com

(C) 2021 Electronic News Publishing, source ENP Newswire